Shlevin Harold H. sold GALT

June 29, 2026 · Form 4 insider transaction

Shlevin Harold H. sold 22,268 shares of Galectin Therapeutics Inc. at $5.04 per share, a transaction worth $112.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
22,268
Price
$5.04
Total value
$112.2K
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateJune 29, 2026
Filing dateJune 30, 2026
Shares owned after6,500
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29. 2025, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on November 14, 2025; The shares were sold in multiple transactions at prices ranging from $5.00 to $5.12. This amount represents the weighted average sale price of such transactions. The reporting person undertakes to provide full information regarding the number of shares sold at each separate price upon request by the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

View the original Form 4 on SEC EDGAR